VA
VR Adviser’s Aclaris Therapeutics ACRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,040,754
| Closed | -$7.13M | – | 37 |
|
2023
Q3 | $7.13M | Hold |
1,040,754
| – | – | 0.75% | 29 |
|
2023
Q2 | $10.8M | Hold |
1,040,754
| – | – | 1.73% | 17 |
|
2023
Q1 | $8.42M | Sell |
1,040,754
-3,523,208
| -77% | -$28.5M | 1.64% | 18 |
|
2022
Q4 | $71.9M | Hold |
4,563,962
| – | – | 12.11% | 2 |
|
2022
Q3 | $71.8M | Hold |
4,563,962
| – | – | 11.08% | 2 |
|
2022
Q2 | $63.7M | Hold |
4,563,962
| – | – | 12.55% | 2 |
|
2022
Q1 | $78.7M | Hold |
4,563,962
| – | – | 12.75% | 1 |
|
2021
Q4 | $66.4M | Hold |
4,563,962
| – | – | 9.07% | 2 |
|
2021
Q3 | $82.2M | Hold |
4,563,962
| – | – | 10.55% | 2 |
|
2021
Q2 | $80.1M | Buy |
4,563,962
+843,380
| +23% | +$14.8M | 9.72% | 2 |
|
2021
Q1 | $93.8M | Buy |
3,720,582
+1,765,650
| +90% | +$44.5M | 10.17% | 3 |
|
2020
Q4 | $12.6M | Buy |
+1,954,932
| New | +$12.6M | 1.86% | 15 |
|